Validation and development of new dichoptic VR-gaming method to treat childhood amblyopia; Vedea Amblyopia Therapy (VAT)
Recruiting
- Conditions
- amblyopia10015917
- Registration Number
- NL-OMON51760
- Lead Sponsor
- Vedea Healthware BV
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 74
Inclusion Criteria
informed consent
aged between 4 and 10 years old
wearing full corrected refraction for >=14 weeks
diagnosed with an unilateral anisometric, strabismic and/or deprivation
amblyopia
currently under treatment or starting treatment for unilateral amblyopia
access to an Android device equal to or higher than a Samsung Galaxy S8
Exclusion Criteria
current treatment with atropine penalisation
documented history of severe negative side effects that occur with exposure to
VR usage (eg. seizures or epileptic spasms)
photosensitivity
no developmental delay
coexisting ocular pathology or systemic diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Visual acuity as measured in logmar lines</p><br>
- Secondary Outcome Measures
Name Time Method <p>Compliance</p><br>